Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors

NCT01552356 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

NIH

Sponsor class

Conditions

Solid Neoplasm

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Pazopanib Hydrochloride
OTHER: Pharmacological Study

Sponsor

National Cancer Institute (NCI)